Search Results for "Isogenica Press Release Framework"
Original Source: Isogenica secures European Framework 7 grant worth up to Euros 700,000
Cambridge, UK, 8 April 2012: Isogenica Ltd today announced that it had been successful in securing a Framework 7 grant for €700,000 over the next three years, part of a €5.55 million project with consortium grant funding of €3.99 million. The grant commenced in January 2012. The 10 consortium members are Apogenix GmbH, Biametrics GmbH, Center for Advanced Bioanalysis, German Cancer Research Centre, Isogenica, Karlsruher Institute for Technology (KIT), Microsystems LTD, PEPperPRINT, Tec...
Matching Channels
Synthesis and Release of Thyroid Hormones
Drug Delivery - news, views, blogs
Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery technologies are patent protected formulat...
A glycoengineered, fully humanized IgG1 monoclonal antibody with potential antineoplastic activity. Obinutuzumab, a third generation type II anti-CD20 antibody, selectivity binds to the extracellula...
Disorders of Calcium Concentration
Calcium (Ca) is required for the proper functioning of muscle contraction, nerve conduction, hormone release, and blood coagulation. In addition, proper Ca concentration is required for various othe...
Stress is caused by your perception of situations around you and then the reaction of your body to them. The automatic stress response to unexpected events is known as 'fight or flight'. Dis...
Matching News
Isogenica secures European Framework 7 grant worth up to Euros 700,000
Cambridge, UK, 8 April 2012: Isogenica Ltd today announced that it had been successful in securing a Framework 7 grant for €700,000 over the next three years, part of a €5.55 million pr...
Cambridge UK, 2 November 2010: Isogenica Ltd today announced that it has entered into a collaborative agreement with Professor Sir Tom Blundell of the University of Cambridge. The initial focus of...
RCT partners with Isogenica for large-scale screening of new antibody-derived scaffold platform
US company Research Corporation Technologies, Inc has formed a partnership with Cambridge, UK-based Isogenica to access Isogenica’s CIS display platform for the screening of proprietary libraries of...
Isogenica Ltd expands business development and customer support operations into North America
Californian office established to support existing and prospective customers Cambridge, UK 30 March 2011: Isogenica today announced that it has established a dedicated business development and cus...
06 June 2012: Cambridge & Welwyn Garden City, UK - Isogenica and Biolauncher together with Cresset Group, announce funding from the Technology Strategy Board, the ...
Research Corporation Technologies, Inc. (RCT), of Tucson, has partnered with Isogenica, of Cambridge, U.K., to access Isogenica’s CIS display platform for the screening of propr...
Isogenica today announced the appointment of Göran Forsberg to the Board of Directors. Currently Chief Business Officer (CBO) at Active Biotech in Lund, Sweden, Göran brings extensive in...
Matching PubMed Articles
Targeted synthesis of a 2D ordered porous organic framework for drug release.
A novel 2D porous organic framework based on the nucleophilic substitution of cyanuric chloride has been designed and synthesized successfully, which possesses an ordered structure, permanent porosity...
Trapping Guests within a Nanoporous Metal-Organic Framework through Pressure-Induced Amorphization.
The release of guest species from within a nanoporous metal-organic framework (MOF) has been inhibited by amorphization of the guest-loaded framework structure under applied pressure. Thermogravimetri...
We studied the activity of single neurons in the pre-supplementary motor area (pre-SMA) of macaque monkeys as they performed two visuomotor tasks, called the visual fixation task and the visual fixati...